These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 30473376

  • 1. Impact of PCSK9 loss-of-function genotype on 1-year mortality and recurrent infection in sepsis survivors.
    Genga KR, Lo C, Cirstea MS, Leitao Filho FS, Walley KR, Russell JA, Linder A, Francis GA, Boyd JH.
    EBioMedicine; 2018 Dec; 38():257-264. PubMed ID: 30473376
    [Abstract] [Full Text] [Related]

  • 2. Detrimental effects of PCSK9 loss-of-function in the pediatric host response to sepsis are mediated through independent influence on Angiopoietin-1.
    Atreya MR, Cvijanovich NZ, Fitzgerald JC, Weiss SL, Bigham MT, Jain PN, Schwarz AJ, Lutfi R, Nowak J, Allen GL, Thomas NJ, Grunwell JR, Baines T, Quasney M, Haileselassie B, Alder MN, Lahni P, Ripberger S, Ekunwe A, Campbell KR, Walley KR, Standage SW.
    Crit Care; 2023 Jun 26; 27(1):250. PubMed ID: 37365661
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. PCSK9 loss-of-function variants and risk of infection and sepsis in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) cohort.
    Mitchell KA, Moore JX, Rosenson RS, Irvin R, Guirgis FW, Shapiro N, Safford M, Wang HE.
    PLoS One; 2019 Jun 26; 14(2):e0210808. PubMed ID: 30726226
    [Abstract] [Full Text] [Related]

  • 5. Low Low-Density Lipoprotein Levels Are Associated With, But Do Not Causally Contribute to, Increased Mortality in Sepsis.
    Walley KR, Boyd JH, Kong HJ, Russell JA.
    Crit Care Med; 2019 Mar 26; 47(3):463-466. PubMed ID: 30394916
    [Abstract] [Full Text] [Related]

  • 6. A Genetic Approach to the Association Between PCSK9 and Sepsis.
    Feng Q, Wei WQ, Chaugai S, Carranza Leon BG, Kawai V, Carranza Leon DA, Jiang L, Zhong X, Liu G, Ihegword A, Shaffer CM, Linton MF, Chung CP, Stein CM.
    JAMA Netw Open; 2019 Sep 04; 2(9):e1911130. PubMed ID: 31509211
    [Abstract] [Full Text] [Related]

  • 7. The Effect of PCSK9 Loss-of-Function Variants on the Postprandial Lipid and ApoB-Lipoprotein Response.
    Ooi TC, Krysa JA, Chaker S, Abujrad H, Mayne J, Henry K, Cousins M, Raymond A, Favreau C, Taljaard M, Chrétien M, Mbikay M, Proctor SD, Vine DF.
    J Clin Endocrinol Metab; 2017 Sep 01; 102(9):3452-3460. PubMed ID: 28673045
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Predicting proprotein convertase subtilisin kexin type-9 loss of function mutations using plasma PCSK9 concentration.
    Wanneh E, Luna G, Dufour R, Baass A.
    J Clin Lipidol; 2017 Sep 01; 11(1):55-60. PubMed ID: 28391911
    [Abstract] [Full Text] [Related]

  • 11. PCSK9 Loss-of-Function Variants, Low-Density Lipoprotein Cholesterol, and Risk of Coronary Heart Disease and Stroke: Data From 9 Studies of Blacks and Whites.
    Kent ST, Rosenson RS, Avery CL, Chen YI, Correa A, Cummings SR, Cupples LA, Cushman M, Evans DS, Gudnason V, Harris TB, Howard G, Irvin MR, Judd SE, Jukema JW, Lange L, Levitan EB, Li X, Liu Y, Post WS, Postmus I, Psaty BM, Rotter JI, Safford MM, Sitlani CM, Smith AV, Stewart JD, Trompet S, Sun F, Vasan RS, Woolley JM, Whitsel EA, Wiggins KL, Wilson JG, Muntner P.
    Circ Cardiovasc Genet; 2017 Aug 01; 10(4):e001632. PubMed ID: 28768753
    [Abstract] [Full Text] [Related]

  • 12. Loss-of-Function PCSK9 Mutations Are Not Associated With Alzheimer Disease.
    Paquette M, Saavedra YGL, Poirier J, Théroux L, Dea D, Baass A, Dufour R.
    J Geriatr Psychiatry Neurol; 2018 Mar 01; 31(2):90-96. PubMed ID: 29562810
    [Abstract] [Full Text] [Related]

  • 13. PCSK9 Variants, Low-Density Lipoprotein Cholesterol, and Neurocognitive Impairment: Reasons for Geographic and Racial Differences in Stroke Study (REGARDS).
    Mefford MT, Rosenson RS, Cushman M, Farkouh ME, McClure LA, Wadley VG, Irvin MR, Bittner V, Safford MM, Somaratne R, Monda KL, Muntner P, Levitan EB.
    Circulation; 2018 Mar 20; 137(12):1260-1269. PubMed ID: 29146683
    [Abstract] [Full Text] [Related]

  • 14. Pharmacologic and Genetic Downregulation of Proprotein Convertase Subtilisin/Kexin Type 9 and Survival From Sepsis.
    Lawler PR, Manvelian G, Coppi A, Damask A, Cantor MN, Ferreira MAR, Paulding C, Banerjee N, Li D, Jorgensen S, Attre R, Carey DJ, Krebs K, Milani L, Hveem K, Damås JK, Solligård E, Stender S, Tybjærg-Hansen A, Nordestgaard BG, Hernandez-Beeftink T, Rogne T, Flores C, Villar J, Walley KR, Liu VX, Fohner AE, Lotta LA, Kyratsous CA, Sleeman MW, Scemama M, DelGizzi R, Pordy R, Horowitz JE, Baras A, Martin GS, Steg PG, Schwartz GG, Szarek M, Goodman SG.
    Crit Care Explor; 2023 Nov 20; 5(11):e0997. PubMed ID: 37954898
    [Abstract] [Full Text] [Related]

  • 15. PCSK9 is associated with mortality in patients with septic shock: data from the ALBIOS study.
    Vecchié A, Bonaventura A, Meessen J, Novelli D, Minetti S, Elia E, Ferrara D, Ansaldo AM, Scaravilli V, Villa S, Ferla L, Caironi P, Latini R, Carbone F, Montecucco F, ALBIOS Biomarkers Study Investigators.
    J Intern Med; 2021 Feb 20; 289(2):179-192. PubMed ID: 32686253
    [Abstract] [Full Text] [Related]

  • 16. PCSK9 genetic (rs11591147) and epigenetic (DNA methylation) modifications associated with PCSK9 expression and serum proteins in CAD patients.
    Shyamala N, Gundapaneni KK, Galimudi RK, Tupurani MA, Padala C, Puranam K, Kupsal K, Kummari R, Gantala SR, Nallamala KR, Sahu SK, Hanumanth SR.
    J Gene Med; 2021 Aug 20; 23(8):e3346. PubMed ID: 33885177
    [Abstract] [Full Text] [Related]

  • 17. What is the impact of PCSK9 rs505151 and rs11591147 polymorphisms on serum lipids level and cardiovascular risk: a meta-analysis.
    Qiu C, Zeng P, Li X, Zhang Z, Pan B, Peng ZYF, Li Y, Ma Y, Leng Y, Chen R.
    Lipids Health Dis; 2017 Jun 12; 16(1):111. PubMed ID: 28606094
    [Abstract] [Full Text] [Related]

  • 18. PCSK9 Protein and rs562556 Polymorphism Are Associated With Arterial Plaques in Healthy Middle-Aged Population: The STANISLAS Cohort.
    Ferreira JP, Xhaard C, Lamiral Z, Borges-Canha M, Neves JS, Dandine-Roulland C, LeFloch E, Deleuze JF, Bacq-Daian D, Bozec E, Girerd N, Boivin JM, Zannad F, Rossignol P.
    J Am Heart Assoc; 2020 Apr 07; 9(7):e014758. PubMed ID: 32208829
    [Abstract] [Full Text] [Related]

  • 19. Survival benefit of a low ratio of visceral to subcutaneous adipose tissue depends on LDL clearance versus production in sepsis.
    Lee JGH, Genga KR, Pisitsak C, Boyd JH, Leung AKK, Russell JA, Walley KR.
    Crit Care; 2018 Mar 06; 22(1):58. PubMed ID: 29510719
    [Abstract] [Full Text] [Related]

  • 20. PCSK9 R46L Loss-of-Function Mutation Reduces Lipoprotein(a), LDL Cholesterol, and Risk of Aortic Valve Stenosis.
    Langsted A, Nordestgaard BG, Benn M, Tybjærg-Hansen A, Kamstrup PR.
    J Clin Endocrinol Metab; 2016 Sep 06; 101(9):3281-7. PubMed ID: 27218270
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.